- Home
- ACIU vs LPTH Comparison
ACIU vs LPTH Comparison
Compare ACIU & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- LPTH
- Stock Information
- Founded
- ACIU 2003
- LPTH 1985
- Country
- ACIU Switzerland
- LPTH United States
- Employees
- ACIU N/A
- LPTH N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- LPTH Semiconductors
- Sector
- ACIU Health Care
- LPTH Technology
- Exchange
- ACIU Nasdaq
- LPTH Nasdaq
- Market Cap
- ACIU 213.3M
- LPTH 229.5M
- IPO Year
- ACIU 2016
- LPTH 1996
- Fundamental
- Price
- ACIU $2.48
- LPTH $6.91
- Analyst Decision
- ACIU Strong Buy
- LPTH Strong Buy
- Analyst Count
- ACIU 2
- LPTH 3
- Target Price
- ACIU $10.00
- LPTH $5.33
- AVG Volume (30 Days)
- ACIU 132.0K
- LPTH 1.5M
- Earning Date
- ACIU 11-04-2025
- LPTH 11-06-2025
- Dividend Yield
- ACIU N/A
- LPTH N/A
- EPS Growth
- ACIU N/A
- LPTH N/A
- EPS
- ACIU N/A
- LPTH N/A
- Revenue
- ACIU $36,362,036.00
- LPTH $33,626,969.00
- Revenue This Year
- ACIU N/A
- LPTH $19.59
- Revenue Next Year
- ACIU $1,022.98
- LPTH $47.43
- P/E Ratio
- ACIU N/A
- LPTH N/A
- Revenue Growth
- ACIU 86.71
- LPTH 2.59
- 52 Week Low
- ACIU $1.43
- LPTH $1.11
- 52 Week High
- ACIU $3.98
- LPTH $6.93
- Technical
- Relative Strength Index (RSI)
- ACIU 64.11
- LPTH 76.87
- Support Level
- ACIU $2.12
- LPTH $5.17
- Resistance Level
- ACIU $2.35
- LPTH $5.74
- Average True Range (ATR)
- ACIU 0.13
- LPTH 0.51
- MACD
- ACIU 0.04
- LPTH 0.08
- Stochastic Oscillator
- ACIU 95.74
- LPTH 99.17
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.